Kyverna Therapeutics, Inc. (Nasdaq: KYTX) is a clinical-stage biopharmaceutical company focused on liberating autoimmune patients through the curative potential of cell therapy. Kyverna’s lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback